Dow Up0.07% Nasdaq Up0.61%

More On 009420.KS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


HanAll Biopharma Co., Ltd. (009420.KS)

-KSC
3,895.00 Up 10.00(0.26%) 1:00AM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Net Income (21,499,000) (2,923,000) (14,526,000) 214,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,952,000  1,715,000  1,800,000   -  
Adjustments To Net Income -   -   -   -  
Changes In Accounts Receivables1,905,000  3,737,000  7,276,000   -  
Changes In Liabilities -   -   -   -  
Changes In Inventories(1,221,000)(2,543,000)5,033,000   -  
Changes In Other Operating Activities203,000  (2,072,000)(3,275,000) -  
Total Cash Flow From Operating Activities (7,780,000) 2,197,000   7,414,000   -  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,475,000)(2,185,000)(796,000) -  
Investments -   -   -   -  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities 11,088,000   (20,524,000) 5,349,000   -  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock -   -   -   -  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities15,514,000  (18,345,000)(5,800,000) -  
Total Cash Flows From Financing Activities (10,136,000) 19,816,000   (4,393,000) -  
Effect Of Exchange Rate Changes(61,000)(46,000)29,000   -  
Change In Cash and Cash Equivalents (6,889,000) 1,444,000   8,399,000   -  

Currency in KRW.